van de Water, L. F.
van Kleef, J. J.
Dijksterhuis, W. P. M.
Henselmans, I.
van den Boorn, H. G.
Vaarzon Morel, N. M.
Schut, K. F.
Daams, J. G.
Smets, E. M. A.
van Laarhoven, H. W. M. http://orcid.org/0000-0003-3546-9709
Funding for this research was provided by:
KWF Kankerbestrijding (UVA 2014-7000)
Article History
Accepted: 8 April 2020
First Online: 24 April 2020
Compliance with ethical standards
:
: Prof. dr. van Laarhoven reports grants from the Dutch Cancer Society, during the conduct of the study; personal fees from BMS, Lilly, and Nordic Pharma; and grants and nonfinancial support from Bayer, BMS, Celgene, Jansen, Lilly, Nordic Pharma, Philips, Roche and Servier outside of this work. The other authors declare no conflicts of interest.